Thyroid Function of Former Opioid Addicts on Naltrexone Treatment

Thyroid Function of Former Opioid Addicts on Naltrexone Treatment

In order to assess thyroid function in former opioid addicts undergoing adjunctive naltrexone (NA) p.o. treatment, we studied 24 subjects (BMI±SD: 23.3±3.2 kg/m2) on 50 mg NA p.o. daily for 15 days to 14.5 months continuously. Measurements included thyrotropin (TSH), total thyroxin (TT4), total trii...

Full description

Bibliographic Details
Main Authors:	Ioannis Ilias, Ioannis Kakoulas, Ioulia Christakopoulou, Kyriakos Katsadoros
Format:	Article
Language:	English
Published:	Karolinum Press 2001-01-01
Series:	Acta Medica
Subjects:	Heroin dependence Narcotic antagonists Naltrexone therapeutic use Naltrexone adverse effects Blood thyroid hormones
Online Access:	https://actamedica.lfhk.cuni.cz/44/1/0033/

Similar Items

Acute Myocardial Infarction following Naltrexone Consumption; a Case Report
by: Bita Dadpour, et al.
Published: (2016-12-01)

The role of social isolation in opioid addiction
by: Christie, N.C
Published: (2021)

RATIONALE FOR THE SELECTION OF AUXILIARY COMPONENTS FOR THE NALTREXONE HYDROCHLORIDE NASAL SPRAY
by: Y. M. Domnina, et al.
Published: (2019-01-01)

Low-Dose Naltrexone (LDN)—Review of Therapeutic Utilization
by: Karlo Toljan, et al.
Published: (2018-09-01)

Serious adverse events reported in placebo randomised controlled trials of oral naltrexone: a systematic review and meta-analysis
by: Monica Bolton, et al.
Published: (2019-01-01)

Enhancement of Cisplatin Nephrotoxicity by Morphine and Its Attenuation by the Opioid Antagonist Naltrexone
by: Atefeh Aminian, et al.
Published: (2016-07-01)

Monitoring and Improving Naltrexone Adherence in Patients with Substance Use Disorder
by: Perez-Macia V, et al.
Published: (2021-05-01)

Treatment of repeated self- injurious behaviour with naltrexone: a case report
by: Praveen Navkhare, et al.
Published: (2013-12-01)

Naltrexone Reverses Ethanol Preference and Protein Kinase C Activation in Drosophila melanogaster
by: Rajeswari Koyyada, et al.
Published: (2018-03-01)

The frequency of agitation due to inappropriate use of naltrexone in addicts
by: Sima Siadat, et al.
Published: (2014-01-01)

Prospective of low dose naltrexone use in treatment of autoimmune pathology and endometriosis
by: O. V. Golianovskyi, et al.
Published: (2020-11-01)

The Study of the Demographic and Clinical and Laboratory Findings in Naltrexone Poisoning Patients Admitted to Razi Hospital, Rasht, During 2007-08
by: Morteza Rahbar Taromsar, et al.
Published: (2012-08-01)

Evaluation of Different Doses of Fentanyl in Controlling Agitation in Acute Opioid Withdrawal Syndrome Induced by Naltrexone Misuse
by: Farzad Gheshlaghi, et al.
Published: (2012-03-01)

Anesthesia for opioid addict: Challenges for perioperative physician
by: Rohit Goyal, et al.
Published: (2013-01-01)

Intranasal Low-Dose Naltrexone Against Opioid Side Effects: A Preclinical Study
by: Laura Micheli, et al.
Published: (2020-09-01)

No change in the consumption of thyroid hormones after starting low dose naltrexone (LDN): a quasi-experimental before-after study
by: Guttorm Raknes, et al.
Published: (2020-10-01)

Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectives
by: Tek C
Published: (2016-05-01)

Dominant Dystrophic Epidermolysis Bullosa Pruriginosa Responding to Naltrexone Treatment
by: Kristine A.U. Pallesen, et al.
Published: (2019-09-01)

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide
by: Goli Veeraindar, et al.
Published: (2012-03-01)

Comparison of General Well-being of Patients Undergoing Methadone Maintenance Therapy (MMT) with Patients Undergoing Naltrexone Therapy.
by: Mehdi Sayyah, et al.
Published: (2013-02-01)

Thermosensitive Gels Used to Improve Microneedle-Assisted Transdermal Delivery of Naltrexone
by: Kevin V. Tobin, et al.
Published: (2021-03-01)

Comparison of General Well-being of Patients Undergoing Methadone Maintenance Therapy (MMT) with Patients Under-going Naltrexone Therapy
by: Mehdi Sayyah, et al.
Published: (2013-02-01)

The effects of Naltrexone among alcohol non-abstainers: results from the COMBINE Study
by: Lara Ray, et al.
Published: (2010-10-01)

The effectiveness of naltrexone combined with current smoking cessation medication to attenuate post smoking cessation weight gain: a literature review
by: Raewyn Rees, et al.
Published: (2017-07-01)

Microbiological Estimation of Nasal Spray Containing Naltrexone Hydrochloride
by: Yu. M. Domnina, et al.
Published: (2020-11-01)

The opioid antagonist naltrexone decreases seizure‐like activity in genetic and chemically induced epilepsy models
by: Morgan L. Sturgeon, et al.
Published: (2021-09-01)

The effect of rapid detoxification method with Naltrexone on drug abuse quitting in drug abusers referred to Khorramabad Psychiatric hospital during the first half of the year 2005
by: hedayat Nazari, et al.
Published: (2009-03-01)

Naltrexone maintenance therapy with pellet implantation as an aid for relapse prevention of heroin dependent individuals : a South African perspective
by: Van der Walt, Hugo Denton
Published: (2017)

Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent
by: Sidnee L. Hedrick, et al.
Published: (2021-09-01)

Stellenwert des Opioidantagonisten Naltrexon bei stationär behandelten Borderline-Patienten
by: Meiser, Miriam
Published: (2016)

Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells
by: Natalia Kučić, et al.
Published: (2021-08-01)

Erythrocytes Membrane Alterations Reflecting Liver Damage in CCl₄-Induced Cirrhotic Rats: The Ameliorative Effect of Naltrexone
by: Fatemeh Sarhadi Kholari, et al.
Published: (2016-11-01)

Co-relationship between sexual dysfunction and high-risk sexual behavior in patients receiving buprenorphine and naltrexone maintenance therapy for opioid dependence
by: Santosh Ramdurg, et al.
Published: (2015-01-01)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
by: Daniel Jackson, et al.
Published: (2021-02-01)

Naltrexone and Bupropion Combination Treatment for Smoking Cessation and Weight Loss in Patients With Schizophrenia
by: Xuechan Lyu, et al.
Published: (2018-03-01)

Heroin Dependence in Anuradhapura District, Sri Lanka: A retrospective Audit
by: anuradha ellepola
Published: (2020-10-01)

Comparative Study on the Effect of Risperidone and its Combination with Naltrexone in Pediatric Patients with Autistic Spectrum Disorders: A Clinical Trial Study
by: Fatemeh Moharreri, et al.
Published: (2017-12-01)

Trends in the Use of Naltrexone for Addiction Treatment among Alcohol Use Disorder Admissions in U.S. Substance Use Treatment Facilities
by: Fares Qeadan, et al.
Published: (2021-08-01)

Resistance to Change of Ethanol Self-Administration: Effects of Naltrexone and Extinction
by: Jimenez-Gomez, Corina
Published: (2005)

Approaches to the Development of a Low-dose Naltrexone Preparation in the Form of a Nasal Spray (Review)
by: Yu. M. Domnina, et al.
Published: (2021-02-01)